Radiopharmaceutical product for the treatment of cancer; radiopharmaceutical compounds for the treatment of neuroendocrine tumors; pharmaceutical preparations for the treatment of somatostatin receptor-positive neuroendocrine tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders